✦ LIBER ✦

Clinical expression, genetics and therapy of adenosine deaminase (ADA) deficiency

✍ Scribed by M. S. Hershfield; F. X. Arredondo-Vega; I. Santisteban

Book ID: 110222541
Publisher: Springer
Year: 1997
Tongue: English
Weight: 24 KB
Volume: 20
Category: Article
ISSN: 0141-8955
DOI: 10.1023/a:1005300621350

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sa.95. Longterm Survival and Pegylated A

Sa.95. Longterm Survival and Pegylated Adenosine Deaminase (ADA) Therapy in a Patient with ADA Deficiency

✍ Robert Nelson; Jamie Shmalo; David Williams; Michael Hershfield 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Adenosine deaminase (ADA) in leukemia: C

Adenosine deaminase (ADA) in leukemia: Clinical value of plasma ADA activity and characterization of leukemic cell ADA

✍ Dr. Takayuki Morisaki; Hisaichi Fujii; Shiro Miwa 📂 Article 📅 1985 🏛 John Wiley and Sons 🌐 English ⚖ 724 KB

A 9-yr evaluation of carrier erythrocyte

A 9-yr evaluation of carrier erythrocyte encapsulated adenosine deaminase (ADA) therapy in a patient with adult-type ADA deficiency

✍ Bridget E. Bax; Murray D. Bain; Lynette D. Fairbanks; A David B. Webster; Philip 📂 Article 📅 2007 🏛 John Wiley and Sons 🌐 English ⚖ 740 KB

Long-term efficacy of enzyme replacement

Long-term efficacy of enzyme replacement therapy for Adenosine deaminase (ADA)-deficient Severe Combined Immunodeficiency (SCID)

✍ Belinda Chan; Diane Wara; John Bastian; Michael S. Hershfield; John Bohnsack; Co 📂 Article 📅 2005 🏛 Elsevier Science 🌐 English ⚖ 584 KB

68: Gene Therapy for Adenosine Deaminase

68: Gene Therapy for Adenosine Deaminase (ADA)-Deficient Severe Combined Immune Deficiency (SCID): Comparative Results with or without PEG-ADA Withdrawal and Myelosuppressive Chemotherapy

✍ G. Podsakoff; B.C. Engel; R. Sokolic; D.A. Carbonaro; L. Muul; E. Garabedian; J. 📂 Article 📅 2008 🏛 Elsevier Science 🌐 English ⚖ 87 KB

PEG-ADA: An alternative to haploidentica

PEG-ADA: An alternative to haploidentical bone marrow transplantation and an adjunct to gene therapy for adenosine deaminase deficiency

✍ Michael S. Hershfield 📂 Article 📅 1995 🏛 John Wiley and Sons 🌐 English ⚖ 596 KB

PEG-ADA is a long-circulating form of adenosine deaminase (ADA) that has been in use for > 8 years as replacement therapy for severe combined immunodeficiency disease due to ADA deficiency. Treatment with PEG-ADA almost completely corrects metabolic abnormalities, allowing the recovery of a variable